Short Summary
The Central Division of the Unified Patent Court in Paris rejected the defendants' request to change the language of proceedings from German to English in two related cases concerning European Patent EP 3 762 212 B1. The court held that there is no legal basis under the UPCA or the Rules of Procedure for changing the language of proceedings before the Central Division, as Article 49(6) UPCA establishes the patent language as the mandatory language of proceedings. The court also rejected the defendants' subsidiary requests to file submissions in English and to conduct the interim conference and oral hearing in English, while granting leave to appeal on the ground that the question is of fundamental importance.
Detailed Summary
This order was issued by the Court of First Instance of the Unified Patent Court, Central Division Paris, on 17 August 2026, in two consolidated proceedings (UPC_CFI_2020/2025 and UPC_CFI_2034/2025) concerning European Patent EP 3 762 212 B1. The plaintiff, SprintRay Inc. of Los Angeles, USA, represented by Herbert Smith Freehills Kramer LLP, filed both a declaration of non-infringement action and a revocation action against the defendants, two parties based in Liechtenstein, represented by Bird & Bird (Netherlands) LLP. The patent at issue was granted in German, and pursuant to Rule 46.6 RoP, the proceedings had been conducted in German as the language of the patent.
On 1 August 2026, the defendants filed submissions in English requesting, under Rule 9 RoP, that the language of proceedings be changed to English. In the alternative, they requested permission to file submissions in English, to conduct the interim conference and oral hearing in English, and to bring their own interpreters at their own cost under Rule 109 RoP. The defendants argued that they were in a weaker position before the Central Division because they could not choose the language, that English is the predominant language of the unitary patent system and the European Patent Office, that the technical documentation was largely in English, that prior correspondence had been in English, and that analogous application of Article 49(3), (4) and (5) UPCA and Rules 321 et seq. RoP was necessary to correct this imbalance. The plaintiff opposed the requests, arguing that German was the statutory language of proceedings before the Central Division as the language of the patent, that the legislative text was clear and contained no exceptions, and that Article 49(6) UPCA was a conclusive, non-analogizable provision. The plaintiff further noted that the defendants, as inventors and patent proprietors domiciled in Liechtenstein, had themselves chosen to file the patent in German and must expect related disputes to be conducted in German.
The presiding judge referred the matter to the panel under Rule 102.1 RoP as a question of fundamental importance. The court first addressed admissibility, noting that under Article 49(6) UPCA the language of proceedings was German and that the defendants' requests, having been filed in English, were inadmissible as not being in the language of proceedings. Nevertheless, the court addressed the merits for reasons of efficiency under Recital 4 of the RoP.
On the merits, the court held that Article 49(6) UPCA unambiguously establishes the language of the patent as the language of proceedings before the Central Division, and that the legislature deliberately did not provide a procedure for changing the language of proceedings before the Central Division comparable to Rule 323.1 and 323.2 RoP applicable to local and regional divisions. The court rejected the defendants' reliance on Rule 9.1 RoP, holding that the general powers conferred by that rule are aimed at efficient management of proceedings and cannot be used to supplement the exhaustive language rules of Article 49 UPCA. The court further rejected the argument for analogous application of the language-change provisions applicable to local and regional divisions, finding no unintentional regulatory gap: the absence of a correction mechanism for the Central Division was a deliberate legislative choice, not an oversight. This conclusion was reinforced by Rule 39 RoP, which contemplates that proceedings transferred to the Central Division, including revocation counterclaims, are conducted in the language of the patent and that the Central Division may even require translation of prior submissions. The court therefore found no room for an individual assessment of the parties' interests.
The court also rejected the subsidiary requests. The request to file submissions in English was rejected because the language of proceedings is binding and there is no legal basis for deviation; prior art may be submitted in English if the court dispenses with translation under Article 51(1) UPCA. The request to conduct the interim conference and oral hearing in English was rejected because Rule 105.3 RoP requires agreement of the parties' representatives for deviation from the language of proceedings in interim conferences, which was not present, and because the language of proceedings is mandatory for the oral hearing. The request for permission to bring interpreters at the defendants' own cost was rejected as inadmissible due to non-compliance with the language of proceedings, though the court expressed no substantive objection and suggested the defendants reformulate the request in German or contact the registry directly.
Finally, the court granted leave to appeal under Rule 220.2 RoP, finding that the question of whether a change of language of proceedings is possible before the Central Division is of fundamental importance. The operative order rejected all of the defendants' requests.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Paris Division. Understanding the court's reasoning in SprintRay Inc. vs Liechtenstein (UPC_CFI_2020/2025, UPC_CFI_2034/2025) is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Rematec GmbH & Co KGvsEurope Forestry B.V.
The Court of Appeal of the Unified Patent Court refused leave to appeal against an order of the Local Division Mannheim that had rejected Rematec's two cost determination applications as time-barred and dismissed its applications for reinstatement. The Court held that an application for leave to appeal under Rule 157 in conjunction with Rule 221 of the Rules of Procedure is inadmissible insofar as it is directed against the rejection of a reinstatement application, since Rule 320.7 expressly precludes appeals against orders on reinstatement. The Court also rejected Europe Forestry's request to impose costs on Rematec, noting that cost reimbursement is generally not available in cost determination proceedings.
Rematec GmbH & Co KGvsEurope Forestry B.V.
The Court of Appeal of the Unified Patent Court refused leave to appeal against an order of the Local Division Mannheim that had rejected Rematec's two cost determination applications as time-barred and denied reinstatement into the missed deadlines. The Court of Appeal held that an application for leave to appeal under R. 157 and R. 221 RoP is inadmissible insofar as it challenges the rejection of a reinstatement application, because R. 320.7 RoP expressly excludes appeals against orders on reinstatement. No arguable grounds for leave to appeal were identified regarding the rejection of retroactive deadline extension requests.
Promosome LLC and The Scripps Research InstitutevsBioNTech SE, BioNTech Manufacturing GmbH, BioNTech Manufacturing Marburg GmbH, BioNTech Innovative Manufacturing Services GmbH, BioNTech Europe GmbH, Pfizer Manufacturing Belgium NV, Pfizer SAS, Pfizer AB, and Pfizer, Inc.
This order of the Court of Appeal of the Unified Patent Court concerns three appeals (UPC-CoA-146/2026, UPC-CoA-147/2026, and UPC-CoA-148/2026) relating to EP 2 401 365. The appellants, Promosome LLC and The Scripps Research Institute, sought a one-month extension of the deadline for lodging their Statements of grounds of appeal, citing heavy professional workload and school holiday periods. Both groups of respondents (BioNTech and Pfizer entities) opposed the extension. The Court of Appeal rejected the applications, holding that the circumstances relied upon were foreseeable and did not justify an extension of the procedural time period.
Kodak Holding GmbH, Kodak GmbH, Kodak Graphic Communications GmbHvsFujifilm Corporation
This is a procedural order from the Court of Appeal of the Unified Patent Court concerning European Patent EP 3 511 174. The Respondents (Kodak entities) requested a one-week extension of the deadline to file written comments on the Applicant's (Fujifilm's) request for rehearing. The Court granted the extension until 23 October 2026, finding the request admissible and well-founded because the Applicant had consented, the extension was brief, and the Respondents' representatives had been occupied preparing for a related oral hearing before the Düsseldorf Regional Court that was postponed shortly before the application was filed.
Huawei Technologies Co. Ltd.vsSercomm Italia SRL
This is a procedural order from the Local Chamber Munich of the Unified Patent Court concerning alternative service of process on Sercomm Italia SRL in a patent infringement action involving European Patent EP 3 611 989 B1. After multiple failed attempts to serve the Italian defendant at its registered business address, the rapporteur had previously ordered under Rule 275.2 RoP that the prior service measures constituted valid service. The present order addresses the fact that notification of that earlier order was unsuccessful and directs additional means of notification to ensure the defendant is informed.
Network System Technologies LLCvsQualcomm Incorporated, Qualcomm Technologies, Inc., Qualcomm Germany GmbH
The Court of Appeal of the Unified Patent Court rejected Network System Technologies LLC's (NST) applications for re-establishment of rights under R. 320 RoP. NST had sought to revive its late-filed appeals against the rejection of its R. 190 Applications (production of evidence) in three infringement proceedings against Qualcomm before the Munich Local Division. The Court held that NST failed to demonstrate that all due care had been taken, as the circumstances cited did not constitute exceptional circumstances or excusable error under the precedent set in AIM v Supponor.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.